UnitedHealth Group Incorporated (NYSE:UNH) Stake Decreased by Monetary Management Group Inc.

Monetary Management Group Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 3.4% in the third quarter, HoldingsChannel.com reports. The fund owned 12,313 shares of the healthcare conglomerate’s stock after selling 430 shares during the period. UnitedHealth Group comprises about 2.1% of Monetary Management Group Inc.’s portfolio, making the stock its 8th largest holding. Monetary Management Group Inc.’s holdings in UnitedHealth Group were worth $6,208,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in UNH. Robbins Farley bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $25,000. NewSquare Capital LLC grew its stake in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares during the period. Strategic Investment Solutions Inc. IL bought a new position in shares of UnitedHealth Group during the 1st quarter valued at approximately $35,000. WFA of San Diego LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $39,000. Finally, Annapolis Financial Services LLC grew its stake in shares of UnitedHealth Group by 38.6% during the 3rd quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after acquiring an additional 22 shares during the period. Institutional investors own 85.69% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, Director Stephen J. Hemsley sold 66,081 shares of UnitedHealth Group stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the transaction, the director now owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE UNH traded down $2.74 during trading hours on Friday, hitting $517.35. The company had a trading volume of 1,133,978 shares, compared to its average volume of 4,286,209. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The company has a quick ratio of 0.80, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The business has a fifty day simple moving average of $525.94 and a 200-day simple moving average of $517.66. The firm has a market cap of $478.51 billion, a P/E ratio of 21.73, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter last year, the business posted $5.34 earnings per share. The company’s quarterly revenue was up 14.1% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 27.84 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Oppenheimer restated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Jefferies Financial Group decreased their price objective on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating on the stock in a report on Monday, November 20th. Morgan Stanley decreased their price objective on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a report on Monday, October 23rd. StockNews.com lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 21st. Finally, UBS Group upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $520.00 to $640.00 in a report on Monday, October 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $575.79.

View Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.